The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Nasal administration of opioids for pain management in adults
Abstract
Background: Nasal administration of opioids may be an alternative route to intravenous, subcutaneous, oral transmucosal, oral or rectal administration in some patients. Key features may be self‐administration, combined with rapid onset of action. The aim of this paper is to evaluate the present base of knowledge on this topic. Methods: The review is based on human studies found in Medline or in the reference list of these papers. The physiology of the nasal mucosa and some pharmaceutical aspects of nasal administration are described. The design of each study is described, but not systematically evaluated. Results: Pharmacokinetic studies in volunteers are reported for fentanyl, alfentanil, sufentanil, butorphanol, oxycodone and buprenorphine. Mean times for achieving maximum serum concentrations vary from 5 to 50 min, while mean figures for bioavailability vary from 46 to 71%. Fentanyl, pethidine and butorphanol have been studied for postoperative pain. Mean onset times vary from 12 to 22 min and times to peak effect from 24 to 60 min. There is considerable interindividual variation in pharmacokinetics and clinical outcome. This may partly be due to lack of optimization of nasal formulations. Patient‐controlled nasal analgesia is an effective alternative to intravenous PCA. Adverse effects are mainly those related to the opioids themselves, rather than to nasal administration. Some experience with nasal opioids in outpatients and for chronic pain has also been reported. Conclusion: Nasal administration of opioids has promising features, but is still in its infancy. Adequately designed clinical studies are needed. Improvements of nasal sprayer devices and opioid formulations may improve clinical outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Improving the Quality of Reporting of Randomized Controlled Trials: The CONSORT Statement
Begg, C. (1996) · JAMA · doi:10.1001/jama.1996.03540080059030 · Cited by 3,127
Cha, M., Eastwaad, S., Hartan, R., Maher, D., Olkin, I., Pitkin, R., Rennie, D., Schulz, K. F., Simel, D. L., & Straup, D. F. (1996) · Cited by 737
Kida, S., Pantazis, A., & Weller, R. O. (1993) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1993.tb00476.x · Cited by 520
McMartin, C., Hutchinson, L. E. F., Hyde, R., & Peters, G. E. (1987) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600760709 · Cited by 349
Drainage of cerebral interstitial fluid into deep cervical lymph of the rabbit
Bradbury, M. W., Cserr, H. F., & Westrop, R. J. (1981) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1981.240.4.f329 · Cited by 335
Drug Metabolism in the Nasal Mucosa
Sarkar, M. A. (1992) · Pharmaceutical Research · doi:10.1023/a:1018911206646 · Cited by 250
Bioadhesive microspheres as a potential nasal drug delivery system
Illum, L., Jørgensen, H., Bisgaard, H., Krogsgaard, O., & Rossing, N. (1987) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(87)90216-x · Cited by 248
Peptide and protein drug delivery
(1993) · Comparative Biochemistry and Physiology Part A: Physiology · doi:10.1016/0300-9629(93)90342-2 · Cited by 227
Hussain, A. A. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(97)00060-4 · Cited by 197
Nasal absorption of propranolol in humans
HUSSAIN, A. A., Foster, T. S., Hirai, S., Kashihara, T., Batenhorst, R. L., & Jones, M. (1980) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600691037 · Cited by 144
Postoperative Pain Management by Intranasal Demand-adapted Fentanyl Titration
Striebel, H. W., Koenigs, D., & Krämer, J. (1992) · Anesthesiology · doi:10.1097/00000542-199208000-00010 · Cited by 143
Comparison of intravenous and intranasal sufentanil absorption and sedation
Helmers, J. H. J. H., Noorduin, H., Peer, A. V., van Leeuwen, L., & Zuurmond, W. W. A. (1989) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03005373 · Cited by 143
Subarachnoid Space of the CNS, Nasal Mucosa, and Lymphatic System
Jackson, R. T., Tigges, J., & Arnold, W. J. (1979) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1979.00790160014003 · Cited by 143
Rhinitis: Mechanisms and Management
Naclerio, R. M., Durham, S. R., & Mygind, N. (1998) · Medical Entomology and Zoology · Cited by 107
Ultrastructural morphology of the olfactory pathway for cerebrospinal fluid drainage in the rabbit
Erlich, S. S., McComb, J. G., Hyman, S., & Weiß, M. (1986) · Journal of neurosurgery · doi:10.3171/jns.1986.64.3.0466 · Cited by 103
Transnasal butorphanol: a new method for pain relief in post‐cesarean section pain
Abboud, T. K., Zhu, J., Gangolly, J., Longhitano, M., Swart, F., Makar, A., Chu, G., COOL, M., Mantilla, M., Kurtz, N., et al. (1991) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1991.tb03234.x · Cited by 103
Bile salts and intranasal drug absorption
Duchateau, G. S. M. J. E., Zuidema, J., & Merkus, F. W. H. M. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90153-5 · Cited by 98
Pontiroli, A. E., Calderara, A., & Pozza, G. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198917050-00001 · Cited by 91
The nasal route of cerebrospinal fluid drainage in man. A light–microscope study
Hendèn, P. L., Johansson, B. B., & Nordborg, C. (1994) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1994.tb01008.x · Cited by 90
The influence of solution viscosity on nasal spray deposition and clearance
Pennington, A. K., Ratcliffe, J. H., WILSON, C. G., & Hardy, J. G. (1988) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(88)90277-3 · Cited by 88
Intranasal fentanyl titration for postoperative pain management in an unselected population
Striebel, H. W., Pommerening, J., & RIEGER, A. (1993) · Anaesthesia · doi:10.1111/j.1365-2044.1993.tb07583.x · Cited by 86
Pharmacokinetic comparison of intravenous and intranasal administration of oxycodone
Takala, A., Kaasalainen, V., Seppälä, T. T., Kalso, E. A., & Olkkola, K. T. (1997) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1997.tb04684.x · Cited by 85
Lehmann, K. A., Gerhard, A., Horrichs-Haermeyer, G., et al. (1991) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.1991.tb03277.x · Cited by 80
Pharmacokinetics of intranasal alfentanil
Schwagmeier, R., Boerger, N., Meißner, W., & Striebel, H. W. (1995) · Journal of Clinical Anesthesia · doi:10.1016/0952-8180(94)00023-w · Cited by 79
Rosenstock, C. V., Møller, J., & Hauberg, A. (2001) · Acta Anaesthesiologica Scandinavica · doi:10.1034/j.1399-6576.2001.450109.x · Cited by 79
Xenobiotic-metabolizing enzymes in human respiratory nasal mucgsa
Gervasi, P. G., Longo, V. G., Naldi, F., Panattoni, G., & Ursino, F. (1991) · Biochemical Pharmacology · doi:10.1016/0006-2952(91)90474-j · Cited by 75
Multiple-dose phase I study of transnasal butorphanol
Shyu, W. C., Pittman, K. A., Robinson, D., & Barbhaiya, R. H. (1993) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1993.106 · Cited by 74
Mechanism of nasal absorption of drugs.
Aa, H. (1989) · PubMed · Cited by 73
Absorption of recombinant methionyl-human growth hormone (Met-hGH) from rat nasal mucosa
Daugherty, A. L., Liggitt, H. D., McCabe, J. G., Moore, J. A., & Patton, J. S. (1988) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(88)90289-x · Cited by 65
Transnasal butorphanol tartrate for pain control following ambulatory surgery
Wetchler, B. V., Alexander, C. D., & Uhll, M. A. (1992) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80464-3 · Cited by 63
Lehmann, K. A., Heinrich, C., & van Heiss, R. (1988) · PubMed · Cited by 62
Zeppetella, G. (2000) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(00)00180-9 · Cited by 61
Peptide and protein drug delivery
(1993) · General Pharmacology The Vascular System · doi:10.1016/0306-3623(93)90049-4 · Cited by 53
Pharmakokinetische Studie zur intranasalen Gabe von Fentanyl
Striebel, H. W., Krämer, J., Luhmann, I., Rohierse-Hohler, I., & Rieger, A. (1993) · Der Schmerz · doi:10.1007/bf02527870 · Cited by 51
The systemic availability of buprenorphine administered by nasal spray
Eriksen, J., Jensen, N., Kamp-Jensen, M., Bjarnø, H., Friis, P., & BREWSTER, D. W. (1989) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1989.tb06374.x · Cited by 46
Pharmacokinetic and Pharmacodynamic Response after Intranasal Administration of Diazepam to Rabbits
Bechgaard, E., Gizurarson, S. S., & Hjortkjaer, R. K. (1997) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1997.tb06105.x · Cited by 45
Glutathione transferases in human nasal mucosa
Aceto, A., Ilio, C. D., Angelucci, S., Longo, V. G., Gervasi, P. G., & Federici, G. (1989) · Archives of Toxicology · doi:10.1007/bf00316443 · Cited by 40
Lehmann, K. A., Ribbert, N., & Horrichs-Haermeyer, G. (1990) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(90)90019-g · Cited by 34
Olfactory Absorption of Insulin to the Brain
Sigurdsson, P., Thorvaldsson, T., Gizurarson, S. S., & Gunnarsson, E. (1997) · Drug Delivery · doi:10.3109/10717549709051892 · Cited by 34
Acetone-dependent regulation of cytochromes P4502E1 and P4502B1 in rat nasal mucosa
Longo, V. G., & Ingelman‐Sundberg, M. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90635-a · Cited by 31
The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis
Shyu, W. C., Pittman, K., Robinson, D. S., & Barbhaiya, R. H. (1993) · European Journal of Clinical Pharmacology · doi:10.1007/bf00315315 · Cited by 30
Selective delivery of insulin into the brain: Intraolfactory absorption
Gizurarson, S. S., Thorvaldsson, T., Sigurdsson, P., & Gunnarsson, E. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(97)97185-4 · Cited by 22
McMartin, C. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78680-8_13 · Cited by 19
Vachharajani, N. N., Shyu, W. C., Garnett, W. R., Morgenthien, E. A., & Barbhaiya, R. H. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)90055-7 · Cited by 15
Pharmacokinetics of butorphanol nasal spray in patients with renal impairment
Shyu, W. C., Morgenthien, E. A., & Barbhaiya, R. H. (1996) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1996.03327.x · Cited by 10
Cited by
Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Keller, L.-A., Merkel, O., & Popp, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00891-5 · Cited by 591
Pectin in controlled drug delivery – a review
Liu, L., Fishman, M. L., & Hicks, K. B. (2006) · Cellulose · doi:10.1007/s10570-006-9095-7 · Cited by 287
Nanosystems in nose-to-brain drug delivery: A review of non-clinical brain targeting studies
Pires, P. C., & Santos, A. O. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.047 · Cited by 228
Intranasal administration of oxytocin: behavioral and clinical effects, a review
Veening, J. G., & Olivier, B. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.04.012 · Cited by 169
Clinical Pharmacokinetics and Pharmacodynamics of Naloxone
Saari, T. I., Strang, J., & Dale, O. (2024) · Clinical Pharmacokinetics · doi:10.1007/s40262-024-01355-6 · Cited by 77
Self-citation
Metadata
- Authors
- Dale, O., Hjortkjær, R., & Kharasch, E. D.
- Venue
- Acta Anaesthesiologica Scandinavica
- Publisher
- Wiley
- Published
- 2002-07-24
- Volume
- 46
- Issue
- 7
- Pages
- 759-770
- ISSN
- 0001-5172 (ISSN-L)
- 1399-6576
- OpenAlex
- W2089978730
- Cited by
- 270
- References
- 45
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.